Clinical Results of Treatment of Postsurgical Endotoxin-Mediated Sepsis With Polymyxin-B Direct Hemoperfusion

Transplantation Proceedings

Volumn 42, Issue 4, 2010, Pages 1021-1024

  Novelli, G ^a   Ferretti, G ^a   Poli, L ^a   Pretagostini, R ^a   Ruberto, F ^a   Perrella, S M ^a   Levi, S ^a   Morabito, V ^a   Berloco, P B ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; OXYGEN; POLYMYXIN B; TORAYMYXIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; ENDOTOXEMIA; FEMALE; HEART RATE; HEMOPERFUSION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HUMAN CELL; INFECTION RISK; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; MULTIPLE CYCLE TREATMENT; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SURVIVAL TIME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; BACTERIAL INFECTIONS; BLOOD PRESSURE; ENDOTOXINS; FEMALE; HEART RATE; HEMOPERFUSION; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYMYXIN B; POSTOPERATIVE COMPLICATIONS; SEPSIS;

EID: 77952558700     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.03.056     Document Type: Article

References (19)

1. Faist E., Wichmann M., and Kim C. Immunosuppression and immunomodulation in surgical patients. Curr Opin Crit Care 3 (1997) 293
2. Beutler B., and Poltrak A. The search for LPS 1993-98. J Endotoxin Res 6 (2000) 269
3. Anspach F.B. Endotoxin removal by affnity sorbents. J Biochem Biophys Meth 49 (2001) 665
4. Cruz D.N., Antonelli M., Fumagalli R., et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301 (2009) 2445
5. Cruz D.N., Perazella M.A., Bellomo R., et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 11 (2007) R47
6. Cantaluppi V., Assenzio B., Pasero D., et al. Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intens Care Med 34 (2008) 1638
7. Ruberto F., Pugliese F., D'Alio A., et al. Clinical effects of direct hemoperfusion using a polymyxin-B immobilized column in solid organ transplanted patients with signs of severe sepsis and septic shock: a pilot study. Int J Artif Organs 30 (2007) 915
8. Romaschin A.D., Harris D.M., Ribeiro M.B., et al. A rapid assay of endotoxin in whole blood using autologous neutrophil-dependent chemiluminescence. J Immunol Meth 212 (1998) 169
9. Marshall J.C., Walker P.M., Foster D.M., et al. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit Care 6 (2002) 342
10. Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 7 (2003) 108
11. Vesentini S., Soncini M., Zaupa A., et al. Multi-scale analysis of the Toraymyxin adsorption cartridge: part I, Molecular interaction of polymyxin-B with endotoxins. Int J Artif Organs 29 (2006) 239
12. Fiore G.B., Soncini M., Vesentini S., et al. Multi-scale analysis of the Toraymyxin adsorption cartridge: part II, computational fluid-dynamic study. Int J Artif Organs 29 (2006) 251
13. Opal S.M., Scannon P.J., Vincent J.L., et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180 (1999) 1584
14. Valenza F., Fagnani L., Coppola S., et al. Prevalence of endotoxemia after surgery and its association with ICU length of stay. Crit Care 13 (2009) R102
15. Kushi H., Miki T., Nakahara J., et al. Hemoperfusion with immobilized polymyxin-B column reduces the blood level of neutrophil elastase. Blood Purif 24 (2006) 212
16. Nakamura T., Matsuda T., and Suzuki Y. Polymyxin B-immobilized fiber hemoperfusion in patients with sepsis. Dialy Transplant 32 (2003) 602
17. Opal S.M., and Glück T. Endotoxin as a drug target. Crit Care Med 31 (2003) S57
18. Tani T., Hanasawa K., Kodama M., et al. Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg 25 (2001) 660
19. Nishibori M., Takahashi H.K., Katayama H., et al. Specific removal of monocytes from peripheral blood of septic patients by polymyxin B-immobilized filter column. Acta Med Okayama 63 (2009) 65